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ABSTRACT Enterococcus faecium, natively a gut commensal organism, emerged as a leading cause of multidrug-resistant
hospital-acquired infection in the 1980s. As the living record of its adaptation to changes in habitat, we sequenced the genomes
of 51 strains, isolated from various ecological environments, to understand how E. faecium emerged as a leading hospital patho-
gen. Because of the scale and diversity of the sampled strains, we were able to resolve the lineage responsible for epidemic,
multidrug-resistant human infection from other strains and to measure the evolutionary distances between groups. We found
that the epidemic hospital-adapted lineage is rapidly evolving and emerged approximately 75 years ago, concomitant with the
introduction of antibiotics, from a population that included the majority of animal strains, and not from human commensal
lines. We further found that the lineage that includedmost strains of animal origin diverged from the main human commensal
line approximately 3,000 years ago, a time that corresponds to increasing urbanization of humans, development of hygienic
practices, and domestication of animals, which we speculate contributed to their ecological separation. Each bifurcation was
accompanied by the acquisition of newmetabolic capabilities and colonization traits onmobile elements and the loss of function
and genome remodeling associated with mobile element insertion andmovement. As a result, diversity within the species, in
terms of sequence divergence as well as gene content, spans a range usually associated with speciation.
IMPORTANCE Enterococci, in particular vancomycin-resistant Enterococcus faecium, recently emerged as a leading cause of
hospital-acquired infection worldwide. In this study, we examined genome sequence data to understand the bacterial adapta-
tions that accompanied this transformation frommicrobes that existed for eons as members of host microbiota. We observed
changes in the genomes that paralleled changes in human behavior. An initial bifurcation within the species appears to have oc-
curred at a time that corresponds to the urbanization of humans and domestication of animals, and a more recent bifurcation
parallels the introduction of antibiotics in medicine and agriculture. In response to the opportunity to fill niches associated with
changes in human activity, a rapidly evolving lineage emerged, a lineage responsible for the vast majority of multidrug-resistant
E. faecium infections.
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Antibiotic resistance is a leading threat to human health world-wide that substantially increases the cost of health care (1).
Enterococci emerged in the 1970s and 1980s as leading causes of
antibiotic-resistant infection of the bloodstream, urinary tract,
and surgical wounds (1), contributing to 10,000 to 25,000 deaths
per year in the USA (2). Resistance to antibiotics is common
among enterococci (1), and vancomycin-resistant Enterococ-
cus faecium now represents up to 80% of E. faecium isolates in
some hospitals (3). Agricultural practices have promoted the
emergence of antibiotic resistance (4–6). The use of avoparcin in
animal feed in Europe and elsewhere appears to have contributed
to the proliferation of vancomycin resistance (7–11), and entero-
cocci have begun to transmit vancomycin resistance to
methicillin-resistant Staphylococcus aureus (12).
Previously, we examined a limited sampling of human com-
mensal and hospital isolates of E. faecium and found that by aver-
age nucleotide identity analysis (ANI), some differed by more
than 5%, crossing the threshold used for species identity (13).
Since variation was noted among hospital strains (13–16) and
since little was known about strains from the gastrointestinal (GI)
tracts of domestic and other animals, it was of interest to deter-
mine the scope of diversity within the species and to precisely
define these populations and their origins. We therefore charac-
terized the breadth of the species by sequencing and comparing
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the genomes of 51 strains, sampling all areas of the existing mul-
tilocus sequence type (MLST) phylogeny (Fig. 1).
RESULTS
Phylogenomic reconstruction of E. faecium divergence. We de-
termined the nucleotide sequences of the genomes of 51E. faecium
strains of different MLST types (see Table S1 in the supplemental
material), which were obtained from diverse ecological environ-
ments (see Fig. S1 in the supplemental material) on five conti-
nents, and isolated over the last 60 years (Fig. S1). A single nucle-
otide polymorphism (SNP)-based phylogenetic tree, which
compared these strains to each other and to an additional 22
strains from GenBank (Table S1), was generated based on varia-
tion in 1,344 shared single-copy orthologous groups (ortho-
groups) (Fig. 2). This tree confirmed the deep divide between
clades (clades A and B) (13, 16). Most (5/7) strains isolated from
the feces of nonhospitalized humans cluster in clade B. We were
able to resolve the epidemic hospital strains (clade A1) from a
mixed group of animal strains and sporadic human infection iso-
lates (clade A2). This clade structure was independently recapitu-
lated based on cluster analysis of (i) shared gene content (Fig. S2)
and (ii) gene synteny (Fig. S3).
Clade A1 strains account for the vast majority of human infec-
tion (Fig. 2) and include sequence types (STs) from the clonal
complex 17 (CC17) genogroup (e.g., sequence type 17 [ST17],
ST117, and ST78 [18]) associated with hospital ward outbreaks
around the globe (see Table S1 in the supplemental material).
Interestingly, the three clade A1 strains of animal origin are from
pet dogs, consistent with known links between hospital strains and
household pets (19). Two strains (EnGen0002 and 1_231_408)
possess hybrid genomes, consisting of a background genome of
clade A1, into which 195 kb to 740 kb DNA from a clade B donor
have recombined (Fig. S4).
To understand the forces that gave rise to the observed clade
structure in the context of human activity, we estimated the time
at which these bifurcations occurred, using Bayesian evolutionary
analysis on sampled phylogenetic trees (BEAST) (20). To limit the
confounding effect of recombination, detectable signatures of re-
combination were removed from the analysis using BRATNext-
Gen (21). Concerned that differing stresses in different habitats
could affect mutation rate, we calculated inferred rates of muta-
tion for each clade separately. A significantly higher mutation rate
was found for strains in the hospital-adapted clade A1 (4.9 105
 0.3 105 substitutions per nucleotide per year) than for sister
clade A2 (3.6  106  0.6  106 substitutions per nucleotide
per year). The mutation rate for clade B was intermediate at 1.3
105  0.2  105 substitutions per nucleotide per year, a rate
that is similar to those recently reported for Staphylococcus aureus
(22, 23).
To determine whether the calculated mutation rate differences
reflected historic events or whether they are still experimentally
detectable, the rate of mutation to fosfomycin resistance was mea-
sured for 10 randomly selected strains from each clade. Resistance
was verified for stability by passage in the absence of selection,
followed by retesting. Clade A1 strains yielded spontaneous
fosfomycin-resistant variants at a rate about an order of magni-
tude higher than strains of either clade A2 or clade B (Fig. 3),
paralleling the results of BEAST analysis. Therefore, mutation
FIG 1 goeBURST analysis of 2,273 E. faecium entries in the E. faecium MLST database (http://efaecium.mlst.net), which can be grouped into 773 sequence types
(STs) (brown circles), based upon MLST relatedness. STs included in this study are highlighted in purple.
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rates for each clade inferred by BEAST were used to estimate the
time of divergence between clades A1, A2, and B. This placed the
time of the initial split between clade A and clade B at 2,776 
818 years ago and that between clade A1 and clade A2 at 74 
30 years ago (Fig. 2).
Gene content differences. Gene gain and loss make funda-
mental contributions to new habitat adaptation and the emer-
gence of new lineages (24). Strains from clade A1 were found to
have significantly larger overall average genome size (2,843 159
genes; 2.98  0.15 Mb) than strains of either clade A2 (2,597 
153 genes; 2.75 0.14 Mb) or clade B (2,718 120 genes; 2.84
0.1 Mb) (Fig. 4A), indicating that perpetuating cycles of infection
and survival in the hospital are associated with acquisition of new
functions. Clade A1 strains also have larger core genomes (1,945
genes) than strains of clade A2 (1,724 genes) or clade B (1,805
genes), which is consistent with a very recent emergence of this
FIG 2 RAxML SNP-based tree based on the concatenated alignments of DNA sequences of 1,344 single-copy core genes in 73 E. faecium genomes. Bootstrap-
ping was performed with 1,000 replicates. The origins of the strains are indicated. The dates for the split between the clades, estimated by a BEAST analysis, are
indicated (ya, years ago). The infectivity score reflects the number of strains of a particular ST, in the MLST database, isolated from infection. The clades are color
coded as follows: clade B in dark blue, clade A1 in red, and clade A2 in gray.
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lineage (i.e., little time for divergence between strains to occur)
(Fig. 4C). In contrast, the pan-genome of clade A2 is larger (6,343
genes) than those of clade A1 and B (5,663 and 5,551 genes, re-
spectively) (Fig. 4B), which is consistent with the diverse origins of
strains from this clade. In comparison to other opportunists, the
E. faecium genome is relatively open (see Fig. S5 in the supplemen-
tal material).
Previously, the genomes of hospital strains of the sister species,
Enterococcus faecalis, were found to differ from commensal organ-
isms largely as the result of mobile element acquisition (13), which
was associated with the absence of CRISPR (clustered regularly
interspaced short palindromic repeat) protection (25). It was,
therefore, of interest to determine the extent to which mobile
elements drove the divergence of E. faecium clades. Mobile ele-
ments were identified using PHAST (26) for phages, SIGI-HMM
(27) for genomic islands, and BLAST for repA orthologs in
plasmid-related contigs (28). Clade A1 was found to be enriched
in mobile elements, including plasmids (5.4  1.9 plasmids/ge-
nome in clade A1, compared to 2.7 2.2 and 1.5 1.1 plasmids/
genome in clade A2 and B strains, respectively), integrated phages
(1.6 0.9 phages/genome, compared to 0.7 0.7 and 0.9 0.8
phages/genome in clade A2 and B strains, respectively) and other
genomic islands (36  26 kb of island-associated sequence/ge-
nome, compared to 14 10 and 17 11 kb of island-associated
sequence/genome in clade A2 and B strains, respectively)
(Fig. 4D). Because the genome sequences generated in the present
study were of high quality, yielding a small number of scaffolds
FIG 3 Frequency of fosfomycin resistance was determined in triplicate for 10
randomly selected strains from each E. faecium clade (clade A1 [red], A2
[gray], and B [dark blue]). Each symbol represents the average value for one
strain, and the clade average  standard deviation (error bars) for the 10
strains per clade are indicated.
FIG 4 (A) Genome size comparison for E. faecium clade A1 (red), A2 (gray), and B (dark blue). (B and C) Pan-genome (B) and core genome (C) are shown for
increasing values of the number of sequenced E. faecium genomes within each clade. Circles represent the number of new or core genes present when a particular
genome is added to each subset. Black bars represent median values. The curve for the estimation of the size of the E. faecium pan-genome for each clade is a
least-squares power law fit through medians. The size of the core genome within each clade was estimated by fitting an exponential curve through medians. (D)
Heat map showing the enrichment in genetic mobile elements in E. faecium genomes within each clade (clade A1 [red], A2, [gray], and B [light blue]). Horizontal
boxes represent strains, which are ordered within clades as in Fig. 2 (rotated 90°). The aggregate length (kb) of islands was used to compare content in each clade
(ranging from 4 kb to 99 kb; median, 17 kb), whereas the numbers of putative plasmids (ranging from 0 to 9; median, 3) or phage elements (ranging from 0 to
4; median, 1) are represented. The heat map reflects the 10th percentile (light gray), 50th percentile (medium gray), and 90th percentile (black). The “” symbol
in a box indicates genome sequence for which the length of genomic islands could not be determined using the SIGI-HMM algorithm (27).
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(see https://olive.broadinstitute.org/projects/work_package_1
/downloads), we were able to quantify and determine the rate of
occurrence and location of IS elements. IS element occurrence
ranges from a low of 2.6 per Mbp (clade B strain EnGen0047) to a
high of 50.7 IS elements per Mbp (clade A2 strain EnGen0024).
Three IS elements (ISEnfa3, ISSpn10, and IS16) are highly en-
riched in clade A1 and are found outside this clade only in a single
clade A2 strain (EnGen0024) and the clade A1/B hybrid strain,
EnGen0002 (Fig. 5). On average, strains of clade A1 harbored a
total of 391 kb of mobile element DNA, and clade A harbored an
average of 332 kb. Clade B strains contained an average of 340 kb
of mobile element DNA.
To identify functional differences and remaining differences in
gene content not restricted to mobile elements, we next identified
orthogroups present in 80% of genomes of one clade but in
20% of strains from a comparator (see Table S2 in the supple-
mental material). Contiguous groups of genes were identified and
associated with the mobile elements identified above where pos-
sible. To begin to understand the ecological forces that led to the
initial bifurcation between clades A and B, we identified genes
occurring in most clade A (A1 plus A2) strains but that were rare
in clade B and vice versa. We found 66 orthogroups enriched at the
level of 80% in clade A and 20% in clade B and 138 ortho-
groups enriched in clade B versus clade A (Table S2). Genes en-
riched in clade A strains largely occurred in 12 clusters of contig-
uous genes (cluster 2 [C2], C8, C10, C11, C12, C17, C19, C20,
C21, C22, C23, and C24), with 8 clusters occurring in identifiable
mobile elements. Cluster 10, 11, 12, and 24 genes encode func-
tions related to altered carbohydrate utilization (Table 1 and Ta-
ble S2). Cluster 19 genes include ABC transporters putatively re-
lated to antibiotic transport. Other genes enriched in clade A
strains, with predicted roles in adapting to different habitats, in-
clude genes encoding a putative membrane-bound metallopro-
tease in cluster 17 that likely confers resistance to a cognate bac-
teriocin (29), and an LPXTG-anchored collagen adhesin in cluster
21 that may relate to colonization and niche selection (30). Indi-
vidual genes showing an enrichment in clade A versus clade B
strains include a putative choloylglycine bile hydrolase related to
that known to be important in the pathogenesis of Listeria infec-
tion (31), which may enable E. faecium to colonize regions of the
intestine more proximal to the bile duct.
Genes representing 138 orthogroups were found to be en-
riched in clade B strains compared to clade A strains. These largely
occur in 24 clusters of contiguous genes but this time with few
signatures of mobile elements. Gene groups C33, C35, C37, C43,
C44, C45, C51, and C54 and a single gene (EfmE980_2866) have
predicted roles in carbon metabolism, highlighting the differential
use of carbohydrates by strains of each clade (Table 1; see Table S2
in the supplemental material). Cluster 50 encodes a cysteine-
containing DnaJ-like chaperone, adjacent to a putative metallo-
-lactamase class protein that is likely to be involved in the ho-
meostasis of glutathione pools (since these commensal strains of
E. faecium do not inactivate -lactams), involved in maintenance
of protein structure. A main driver of clade divergence, therefore,
appears to stem from residence in different ecological environ-
ments that have selected for the systematic exchange of phospho-
transferase system (PTS) systems, with strains of clade A acquiring
new PTS systems on mobile elements and deleting obsolete PTS
systems from the clade B chromosome.
Interestingly, cluster 39, which is enriched in clade B, contains
four genes that are predicted to form an agr-like quorum-sensing
system (32), along with another Mga-type regulator that may
connect quorum sensing to carbohydrate utilization (Table 1;
see Table S2 in the supplemental material) (33). Unexpectedly,
cluster 53, with an apparent 98-amino-acid secretion target
(EfmE980_2510), which also is enriched in clade B, appears to
encode a type VII secretion system. Both agr (32) and type VII
secretion systems (34, 35) have been studied for their contribution
to infection pathogenesis, but the pattern of differential presence
observed here highlights potentially important roles in commen-
salism as well.
It was also of interest to examine differential gene presence in
clades A1 and A2. In hospital epidemic clade A1, 48 genes were
identified as differentially present, with 37 genes occurring in 6
FIG 5 Summary of clade-specific antibiotic resistance genes, insertion sequences (IS), and select defenses against horizontal gene transfer. Each box represents
a strain, arranged by clade as shown in Fig. 2. The “” symbol in a box indicates genome sequence with an assembly quality that precluded identification of the
indicated feature. An asterisk in a box indicates hybrid genomes that contain CRISPR-cas on recombined fragments. CRISPR and type IV restriction-
modification (RM) systems are included in the miscellaneous (Misc.) category.
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distinct clusters associated with mobile elements (Table 1; see Ta-
ble S2 in the supplemental material). Interestingly, the split be-
tween clades A1 and A2 is also associated with the gain of pathways
for carbohydrate utilization. Clade A1 strains acquired an appar-
ent mobile element of 13 genes (C6 [Table 1]) encoding enzymes
for uptake and utilization of fructose, sorbose, and mannose. This
appears to be functionally related to a cluster (C36) that earlier
was lost from clade B by strains of clade A. C6 is known to play an
important role in GI tract colonization following antibiotic treat-
ment (36). It is interesting that clade A1 recovered this ability, and
this observation suggests that it may relate to human colonization.
Cluster C16 is also differentially enriched in clade A1 and contrib-
utes to carbohydrate utilization. No orthogroups were enriched in
clade A2 versus clade A1.
TABLE 1 Enrichment of functional gene clusters in E. faecium cladesa
Cluster 
A
vs 
B
A1 
vs 
B
A2 
vs 
B
B
vs 
A
A1 
vs 
A2
Putative function of the cluster or gene of interest
10 PTS system, N-acetylglucosamine-specific
12 PTS system, glucitol/sorbitol-specific
11 Alternate pathways for glycolysis and gluconeogenesis
24 Starch, xylose and sucrose utilization
19 ABC transporter and regulatory proteins
20 ABC transporter of unknown function
23 ABC transporter
17 Bacteriocin self-immunity protease
21 Surface proteins
22 Hexapaptide transferase, LysR substrate binding domain
2 Putative toxin-antitoxin system
8 Unknown
27 PTS system, Glucose/mannose and GlcNAc, ManNAc and Neu5Ac
1 PTS system, Lactose/Cellobiose specific
3 PTS system, glucose specific
18 Enterocin A immunity, Class II bacteriocin
15 ABC transporter of unknown function
5 Regulatory genes, HTH DNA binding domain
14 IS66 family transposase
25 Putative toxin-antitoxin system IS605- and IS200-like
26
4 Unknown
9 Unknown
6 PTS system, mannose/fructose/sorbose specific
16 Glycosyl hydrolase, Sugar uptake systems
7 Phage integrase and excisionase
13 Unknown
28 Transcriptionnal regulator, LPXTG cell wall anchor protein
29 DNA binding regulators
33 PTS system, sorbose specific 
35 PTS system, maltose specific 
36 PTS system, fructose/sorbose specific
43 PTS system sucrose/amylose specific
44 PTS system Lactose/Cellobiose specific
45 PTS system associated Lactose/Cellobiose/maltose
46 Exopolysaccharide biosynhtesis, glycosyltransferase
51 Mga regulators
54 Mga regulator
42 LacG, ABC transporter
30 DNA binding regulator, phospholipase, ABC transporter
31 Putative peptidase, DNA binding regulator
39 AgrABC o peron
37 Chitinase C1, Chitin binding protein, DNA binding regulator
41 GadR/MutR family transcriptionnal regulator, 
50 DnaJ chaperone, Metallo-beta-lactamase class
34 Efflux pump MtrF, beta-Ala-Xaa dipeptidase
53 Putative type VII secretion system
48 Oligopeptide transport system and permease
47
49
38
40 Unknown
32
52
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
a Differentially occurring clusters of genes associated with chromosomal DNA (black), putative ICE elements (integrative and conjugative elements) (dark gray), plasmids (medium
gray), or phages (light gray). Clusters functionally associated with carbohydrate uptake and utilization are indicated in blue type. No genes are differentially enriched in the genomes
of strains in clade A2 compared to clade A1. HTH, helix-turn-helix.
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We identified additional genes that show enrichment in clade
A1 compared to clade B. Gene clusters 1, 3, and 27 putatively
encode proteins for PTS systems and enzymes for the interconver-
sion and metabolism of lactose/cellobiose, glucose, mannose,
N-acetylneuraminate, N-acetylmannosamine, and other sialic ac-
ids. Clusters 1 and 27 are associated with mobile elements. Cluster
18 (C18), which is also enriched in clade A1 compared to clade B,
encodes a three-gene operon for a class II bacteriocin that may be
a colonization factor (Table 1; see Table S2 in the supplemental
material).
Bifurcation of clade A parallels the proliferation of resis-
tance. To understand the role that antibiotics played as a driver of
clade formation, we examined the differential presence of resis-
tance genes (see Table S3 in the supplemental material). Two re-
sistance genes [aac(6’)-li conferring resistance to kanamycin and
bacA conferring bacitracin resistance] are part of the core E. fae-
cium genome. The ubiquitous presence of aac(6’)-li has been ob-
served before and contributes to the intrinsic resistance of E. fae-
cium to several aminoglycosides (37). The bacA gene may be
responsible for intrinsic resistance to bacitracin observed among
E. faecium (38). Seven strains analyzed were isolated in the 1950s
and 1960s, allowing for the identification of genes associated with
some of the earliest known acquired resistances to occur in E. fae-
cium. Strains EnGen0025, EnGen0027, EnGen0031, EnGen0032,
and E1636 were isolated between 1957 and 1965; these strains fall
into clade A2. Each of these strains also possesses the fusA fusidic
acid resistance gene. Additionally, strains EnGen0025, En-
Gen0027, EnGen0031, and E1636 possess the msrC gene, which
confers erythromycin resistance. Strain EnGen0025 additionally
acquired the aminoglycoside resistance genes ant(6’)-la (confer-
ring resistance to streptomycin) and aph(3=)-III (conferring resis-
tance to several aminoglycosides, including neomycin and genta-
micin B), ermB, and tetM. As shown in Fig. 2, this strain (the fifth
strain from the top of clade A2) is closely related to the clade A1
branch point and presumably the clade A1 founder.
Other resistances exhibit clear clade specificity (Fig. 5; see Ta-
ble S3 in the supplemental material). Vancomycin resistance is
completely absent from clade B. Vancomycin resistance occurs
mainly in clade A1 but also occurs in clade A2. Aminoglycoside
resistance genes ant(6’)-la and aph(3=)-III are completely absent
from clade B strains, but they occur in most clade A1 isolates.
Interestingly, in clade B, the msrC resistance gene correlates per-
fectly with the presence of a CRISPR element. We have not found
prior mention of the occurrence of several resistance genes in
E. faecium, including the aadD cassette, which confers resistance
to tobramycin and kanamycin, in a single genome (strain En-
Gen0035). We also observed genes lnuB, ermG, and ermT (that
likely confer various degrees of resistance to the macrolides-
lincosamides-streptogramin B [MLS] class of antibiotics), tetC
(conferring resistance to tetracycline), and fosB (conferring resis-
tance to fosfomycin) in E. faecium.
Clade structure is reflected in E. faecium genome organiza-
tion. The Aus0004 genome possesses a previously identified
683-kb inversion around the replication termination site (17).
Similar inversions appear to have occurred several times indepen-
dently (since boundaries were not strictly identical) in strains of
clades A1 and A2 (i.e., in strains EnGen0007 and EnGen0025), but
not in strains of clade B (see Fig. S6 in the supplemental material).
This inversion is bounded by different phages in different strains,
and it appears that the recombination responsible for this rear-
rangement occurred within the phage sequence. Larger inversions
in other areas of clade A1 and A2 genomes were also observed,
including a 1.2-Mbp inversion in both EnGen0046 and En-
Gen0049, and again appear to be driven by recombination within
phages present at the boundaries. Most genome rearrangements
observed in E. faecium can be linked to the occurrence of mobile
genetic elements at the boundaries. Select novel rearrangements
were arbitrarily verified by PCR, and the accuracy of assembly was
verified in each case.
In addition to mediating inversions and recombinations, in-
troduction and proliferation of IS elements in a bacterial popula-
tion can facilitate adaptation to new niches as the result of obsolete
gene inactivation (1). We identified 133 instances of IS element-
mediated gene inactivation in E. faecium (see Table S4 in the sup-
plemental material). The number of IS-mediated gene inactiva-
tion events was highest in clade A1 genomes and lowest in clade B
strains. In clade A1 strains, we found a strong enrichment for
disruption of a core gene encoding a putative major facilitator
superfamily (MFS) transporter (EFAU004_02447 in strain
AUS0004) (Table S4).
Since compromised defense was associated with the evolution
of hospital epidemic strains of E. faecalis (25), it was of interest to
examine more closely the relationship between the presence of a
CRISPR-Cas system and mobile element content. We therefore
examined the 73 E. faecium genome sequences studied for the
presence of CRISPR-cas using CRISPRfinder (39). Only 7 E. fae-
cium genomes carried cas genes (Fig. 5), and in 5 of these (strains
Com12, EnGen0002, EnGen0056, 1_141_733, and 1_231_408), a
CRISPR array could be readily identified immediately down-
stream. In strains 1_231_408 and EnGen0056, where spacers
could be matched to known genes, one was derived from a phage
that is a common lysogen in E. faecium genomes (present in 39 out
of 73 genomes). Interestingly, this phage is absent from these 2
genomes, suggesting CRISPR-Cas functionality. Notably, all
strains that carry cas genes are either found in a distinct subgroup
within clade B or are hybrid strains 1_231_408 and EnGen0002
that acquired the cas genes and its associated CRISPR-locus from
the clade B parent (see Fig. S4 in the supplemental material). Apart
from the CRISPR defense, we observed a gene encoding a putative
type IV methyl-directed restriction enzyme in strains of both clade
B and A2, but not in clade A1 genomes (Fig. 5).
Evidence of varying selection in genomes from each clade.
We examined polymorphisms in shared genes to detect genes un-
der particularly strong selection in the different habitats occupied
by strains of each clade. Because of the clade structure, we used a
tree-based approach (40) to compare the ratios of nonsynony-
mous to synonymous base changes (dN/dS ratio). We removed
potentially confounding (41) recombined fragments using BRAT-
NextGen (21). Genes under positive selection were identified
when the dN/dS ratio in the clade of interest (foreground) was
observed to be significantly higher than the dN/dS ratio in the
comparator genomes (background) (see Table S4B in the supple-
mental material). No genes were found to be under positive selec-
tion in clade B compared to clades A, A1, and A2, likely reflecting
the fact that clade B strains had long-fixed beneficial mutations in
this particular niche before the emergence of the A clade. Only
four genes were found to be under differential positive selection
pressure in clade A compared to clade B, two of which were anno-
tated as having roles in amino acid transport and metabolism
(Table S4B). Interestingly, in strains of the hospital-adapted clade
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A1, a penicillin binding protein transpeptidase and the D-alanyl-
D-alanine ligase were under differential positive selection com-
pared to strains of both clades A2 and clade B (Table S4B). Finally,
an MFS transporter involved in carbohydrate transport and me-
tabolism in clade A1 and an N-acetylglucosamine transferase in
clade A2 were found to be under positive selection pressure, pro-
viding independent support for the importance of differential car-
bohydrate utilization as a determinant of clade structure, as in-
ferred from gene gain/loss patterns described above.
DISCUSSION
Speciation results from expansion into new ecological niches and
subsequent isolation from the founder population (42) and is ac-
companied by changes in the genome stemming from mutation,
recombination (43), and horizontal gene transfer (44). All of these
processes have contributed to the current population structure of
E. faecium and its emergence as a leading multidrug-resistant hos-
pital pathogen.
Quantification of mutation rates for strains in each E. faecium
clade allowed us to estimate that the first bifurcation in the E. fae-
cium population took place approximately 3,000 years ago, sub-
stantially sooner than previously suggested (16). Although it is
difficult to know the ecological drivers of this split with precision,
the timing suggests that it relates to increasing insulation between
the flora of humans and animals, which likely stemmed from in-
creased urbanization, increased domestication of animals provid-
ing restricted and specialized diets (45, 46), and increasing use of
hygienic measures (47, 48). This bifurcation was associated with a
wholesale loss and replacement of carbohydrate utilization path-
ways, mediated largely by acquisition on mobile elements by
strains of clade A. Many of the clade B pathways lost by clade A
strains relate to the utilization of complex carbohydrates from
dietary sources, and the pathways lost were replaced by pathways
on mobile elements associated with the utilization of amino sug-
ars, such as those occurring on epithelial cell surfaces and in mu-
cin, suggesting a possible shift from a lifestyle dependent mainly
on host diet (clade B) to one increasingly dependent on host se-
cretions (clade A). In addition to carbohydrate utilization path-
ways, there was a substantial shift in genes encoding Mga-type
helix-turn-helix regulators, which in Streptococcus pyogenes con-
nect expression of niche-specific genes with carbohydrate metab-
olism (33).
The second split in the E. faecium population, the split between
clade A1 and clade A2, appears to have occurred approximately
75 years ago, coinciding precisely with the introduction of antibi-
otics in both clinical medicine and agriculture. However, this split
may not have been directly driven by the usage of antibiotics, as
antibiotics are used both in farming and in human medicine. The
ability to rapidly acquire new traits on mobile elements, including
carbohydrate utilization pathways as well as resistance to antibi-
otics, appears to be an intrinsic trait of clade A1 and clade A2.
Although clade A1 strains now cause the vast majority of infec-
tions (Fig. 2), early clinical isolates from the 1950s and 1960s do
not cluster in clade A1. The earliest isolation of a strain associated
with an MLST type occurring in clade A1, occurred in 1982 (49).
That isolate already possessed high-level resistance to gentamicin
and carried the esp gene.
Interestingly, we found that the recently emergent hospital-
adapted clade A1 is hypermutable, as reflected in the inferred rate
of mutation in the genomes, and experimentally. Hypermutation
in Gram-negative bacteria has been linked to the emergence of
antibiotic-resistant lineages that are pathogenic to humans (50–
52). In Gram-positive bacteria, hypermutating populations of
pathogenic Streptococcus pneumoniae and Staphylococcus aureus
have been observed (53, 54). In E. faecium, polymorphisms in
mutS and mutL (which encode DNA mismatch repair proteins)
have been noted (55), but the polymorphisms are not associated
with differential mutation rates in different clades. Higher muta-
tion rates have been associated with microbes recently experienc-
ing a host switch (e.g.,Mycoplasma gallisepticum, 0.8 105 to 1.2
 105 substitutions per site per year [61]) and with the emer-
gence of pathogenic lineages (52), possibly including E. faecium
strains of the CC17 genogroup (56). It appears that the epidemic
hospital clade A1 emerged because of its ability to acquire mobile
elements, its ability to utilize carbohydrates of nondietary origin,
and its hypermutability.
Previously, the average nucleotide identity of eight E. faecium
strains was determined to range between 93.5 and 95.6% when
comparing strains from clades A and B (13), and clade A and B
strains would be considered to be distinct species by existing cri-
teria (57, 58). The identification of hybrid clade A1/B strains
(strains EnGen0002 and 1_231_408) show that the ecological
niches of human-infecting hospital strains and human commen-
sal strains do occasionally overlap. The emergence of the distinct
clade structure in E. faecium parallels anthropogenic changes in
urbanization and animal domestication and, more recently, the
introduction of antibiotics into agriculture and medicine. The net
effect of these forces is the emergence of a rapidly evolving lineage,
which has crossed a degree of divergence usually associated with
speciation.
MATERIALS AND METHODS
Bacterial strains. Strains selected for genome analysis were drawn from
those representing diverse points within the known phylogenic structure,
as determined by MLST (Fig. 1), and are listed in Table S1 in the supple-
mental material. DNA was purified from each E. faecium strain as de-
scribed before (13) for DNA sequence analysis. Methods for DNA se-
quencing, genome assembly, and bioinformatic analysis are provided in
Supplemental Methods at https://olive.broadinstitute.org/projects/work
_package_1/downloads, along with details of the genome sequences.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org
/lookup/suppl/doi:10.1128/mBio.00534-13/-/DCSupplemental.
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ADDENDUM IN PROOF
Following submission we were made aware that others recently described a
split, between human and bovine populations of S. aureus, datable by BEAST
analysis, to approximately 5,000 years ago (L. A. Weinert, J. J. Welch, M. A.
Suchard, P. Lemey, A. Rambaut, and J. R. Fitzgerald, Biol Lett. 8:829-832,
2012).
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